Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 198 | 74 | 83 | 92 | 2,717 |
| Cost of Goods | N/A | N/A | N/A | N/A | 128 |
| Gross Profit | 198 | 74 | 83 | 92 | 2,589 |
| Operating Expenses | 1,593 | 1,828 | 2,145 | 2,083 | 2,135 |
| Operating Income | -1,395 | -1,754 | -2,062 | -1,991 | 582 |
| Interest Expense | 99 | 119 | 138 | 158 | 177 |
| Pre-tax Income | -1,494 | -1,873 | -2,200 | -2,149 | 405 |
| Net Income Continuous | -1,494 | -1,738 | -2,200 | -2,149 | 405 |
| Net Income | $-1,494 | $-1,738 | $-2,200 | $-2,149 | $405 |
| EPS Basic Total Ops | -0.07 | -0.09 | -0.12 | -0.18 | 0.03 |
| EPS Basic Continuous Ops | -0.07 | -0.08 | -0.13 | -0.18 | 0.03 |
| EPS Diluted Total Ops | -0.07 | -0.09 | -0.12 | -0.18 | 0.03 |
| EPS Diluted Continuous Ops | -0.07 | -0.08 | -0.13 | -0.18 | 0.03 |
| EBITDA(a) | $-1,306 | $-1,663 | $-1,966 | $-1,892 | $689 |